Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNP | P00491 | 2/20 | 0.45 |
| ▸ | QTRT1 | Q9BXR0 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.36 |
| ▸ | TYMS | P04818 | 8/20 | 0.34 |
| ▸ | XDH | P47989 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL97605 | 0.83 | PNP (0.47) | PNPQTRT1CYP1A2DYRK1ATYMS | |
| SCHEMBL21249712 | 0.76 | PNP (0.44) | PNPQTRT1CYP1A2DYRK1ATYMS | |
| SCHEMBL21249696 | 0.76 | PNP (0.47) | PNPQTRT1CYP1A2TYMSXDH | |
| SCHEMBL23394738 | 0.76 | PNP (0.44) | PNPQTRT1CYP1A2XDH | |
| SCHEMBL9544019 | 0.69 | PNP (0.36) | PNPQTRT1CYP1A2DYRK1ATYMS | |
| SCHEMBL30603282 | 0.63 | PNP (0.36) | PNPQTRT1CYP1A2DYRK1ATYMS | |
| Hydrochloric Acid SCHEMBL9544122 | 0.63 | PNP (0.34) | PNP | |
| SCHEMBL20968806 | 0.62 | PNP (0.38) | PNPXDH | |
| SCHEMBL22601502 | 0.62 | TYMS (0.37) | PNPTYMS | |
| SCHEMBL535022 | 0.60 | QTRT1 (0.42) | PNPQTRT1DYRK1ATYMSXDH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024092256-A2 | PEPTIDE-ANTISENSE OLIGONUCLEOTIDES AND THEIR USE FOR TREATMENT OF NEURODEGENERATIVE DISORDERS | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2024-05-02 | — | — | WO | disclosed |